Med Paper (CAS:MDP) 5-Year EBITDA Growth Rate: 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Med Paper 5-Year EBITDA Growth Rate?

Med Paper CAS:MDP -0.91% 5-Year EBITDA Growth Rate is 0.00% as of . 20. The stock has 1 warning sign investors should review.

Med Paper's EBITDA per Share for the six months ended in . 20 was MAD0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Med Paper  (CAS:MDP) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Med Paper 5-Year EBITDA Growth Rate Related Terms

CAS:MDP vs SLVM: 5-Year EBITDA Growth Rate Comparison

For the Paper & Paper Products subindustry, Med Paper's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Med Paper 5-Year EBITDA Growth Rate vs Forest Products Industry

For the Forest Products industry and Basic Materials sector, Med Paper's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Med Paper's 5-Year EBITDA Growth Rate falls into.


Med Paper 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
Med Paper (CAS:MDP) has a 5-Year EBITDA Growth Rate of 0.00% as of . 20. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Med Paper and its competitors.
Is Med Paper's 5-Year EBITDA Growth Rate too high?
Med Paper's current 5-Year EBITDA Growth Rate is 0.00%.
How does Med Paper's 5-Year EBITDA Growth Rate compare to SLVM?
Med Paper's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Forest Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Forest Products company?
A good 5-Year EBITDA Growth Rate depends on the Forest Products industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Med Paper and its competitors. Med Paper's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Paper stock overvalued right now?
Med Paper (CAS:MDP) has a current 5-Year EBITDA Growth Rate of 0.00%. The current 5-Year EBITDA Growth Rate is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Med Paper (CAS:MDP), the current 5-Year EBITDA Growth Rate is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Med Paper Business Description

Address Route de Tetouan Lot 19, BP n 400, Mghogha Industrial Zone, Tangier, MAR, 20400
Med Paper is a specialist paper manufacturer in Morocco.